spironolactone has been researched along with digoxin in 166 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 81 (48.80) | 18.7374 |
1990's | 15 (9.04) | 18.2507 |
2000's | 44 (26.51) | 29.6817 |
2010's | 22 (13.25) | 24.3611 |
2020's | 4 (2.41) | 2.80 |
Authors | Studies |
---|---|
Hashimoto, Y; Ibaramoto, K; Inui, KI; Masuda, S; Saito, H; Takeuchi, A | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Florence, AT; Salole, EG | 1 |
Born, CK; Davidson, CP; Hamrick, ME; Musgrave, GE | 1 |
Lippman, ME; Loriaux, DL; Pita, JC; Thompson, EB | 1 |
Wachter, C; Wood, WG | 1 |
Heinz, N; Rietbrock, N | 1 |
Jefferys, DB | 1 |
Hutcheon, AW; Jick, H; Lawson, DH | 1 |
Lichey, J; Rietbrock, N; Schröder, R | 2 |
Bräuer, H; Müller, H; Resch, B | 1 |
Andersen, JD; Heebøll-Nielsen, N; Moltke, E; Nielsen, OG; Steiness, E; Sørensen, U; Waldorff, S | 1 |
Bass, O; Baur, HR; Masson, JP; Ohnhaus, EE | 1 |
Berger, E; Cristodorescu, R; Deutsch, G; Gavrilescu, S | 1 |
Powers, JL; Sadée, W; Sheiner, LB; Silber, B; Winter, ME | 1 |
Kistner, M; Reisert, VP | 1 |
Boink, AB; Kruyswijk, HH; Maas, AH; Willebrands, AF | 1 |
Masson, JP; Ohnhaus, EE | 1 |
Follath, F; Fridrich, R; Peyer, H; Roth, M; Wenk, M | 1 |
Abshagen, U; Kuhlmann, J; Rennekamp, H | 1 |
Espiner, EA; Hughes, H; Nicholls, MG; Rogers, T | 1 |
Alakare, B; Kärki, NT; Nevasaari, K | 1 |
Olesen, KH; Sigurd, B; Wennevold, A | 1 |
Rietbrock, N; VOHRINGER, HF; Weller, L | 1 |
Köthe, E; Kramer, P; Saul, J; Scheler, F | 1 |
Ravel, R | 1 |
Krusteva, E | 1 |
Hedman, A | 1 |
Angelin, B; Arvidsson, A; Dahlqvist, R; Hedman, A | 1 |
Foukaridis, GN | 1 |
Cacini, W; Wernke, MJ | 1 |
Hicks, JM; Iosefsohn, M; Soldin, SJ | 1 |
Gadsden, RH; Pleasants, RA; Porter, RS; Williams, DM | 1 |
Crothers, DC | 1 |
Frewin, DB; Glistak, ML; Lehmann, DR; Morris, RG; Taylor, WB | 1 |
Burnet, RB; Frewin, DB; Glistak, ML; Lagnado, PY; Lehmann, DR; Morris, RG | 1 |
Koren, G | 1 |
Gibson, TP; O'Brien, MS; Salamone, LF | 1 |
Abshagen, U | 1 |
Koch, K; Mattern, HR; Schaumann, W | 1 |
Frölich, JC; Wirth, KE | 2 |
Klaassen, CD | 1 |
Arbeiter, G; Cordes, R; Kötter, V; Kuhlmann, J; Schröder, R; von Leitner, E | 1 |
Cohn, JN; Franciosa, JA; Mathew, KJ; Snow, JA | 1 |
Fleming, JS | 1 |
Huffman, DH | 1 |
Rawlins, MD | 1 |
Phillips, AP | 1 |
Shah, S | 1 |
Ghabussi, P; Hochrein, H; Krämer, KD | 1 |
Castle, MC; Lage, GL | 1 |
Olesen, KH; Valentin, N | 1 |
Bolte, HD; Buckesfeld, RP; Lankisch, PG; Larbig, D; von Lilienfeld-Toal, H | 1 |
Boink, AB; Jambroes, G; Kruyswijk, HH; Maas, AH; Willebrands, AF | 1 |
Steiness, E | 1 |
Hüsten, J; Ruiz-Torres, A | 1 |
Biamino, G; Dennert, J; Meyer, V; Sadée, W; Schröder, R; Schüren, KP | 1 |
Mécs, I; Selye, H; Tamura, T | 1 |
Betzien, G; Krecke, HJ; Timmler, R | 1 |
Bacciarelli, C | 1 |
Klaassen, CD; Siegers, CP | 1 |
Cape, RD; Finnegan, TP; Spence, JD | 1 |
Jahodová, J; Kölbel, F; Kubová, V; Pribyl, T; Schreiber, V; Stĕpan, J | 1 |
Gumbiner, CH; Howell, DM; Martin, GE | 1 |
Daum, S; Goerg, R; Mack, D; Wang, D | 1 |
Chen, JH; Chen, JS; Hsieh, YY; Hsu, JC; Hsu, KL; Hsu, WS; Lin, MS; Shu, MY; Su, CT; Wu, TL | 1 |
Davidson, KH; McCall, BB; Paladino, JA | 1 |
Fenster, PE; Goodman, MM; Hager, WD | 1 |
Sato, T | 1 |
Berning, J; Buch, J; Egeblad, H; Hansen, PB; Kjaergård, H; Steiness, E; Waldorff, S | 1 |
Scott, B | 1 |
Hjalmarson, A; Swedeberg, K; Waagstein, F; Wallentin, I | 1 |
Maddox, RR; Thomas, RW | 1 |
Fowler, RS; Hobbins, SM; Korey, AG; Rowe, RD | 1 |
Berning, J; Buch, J; Steiness, E; Waldorff, S | 1 |
Soyka, LF | 1 |
Bustrack, JA; Cote, JR; DiPiro, CR; DiPiro, JT | 1 |
Hyneck, ML; Johnson, MH | 1 |
Bergdähl, B; Molin, L | 1 |
Armijo, JA; Padrón, FA | 1 |
Castle, MC | 1 |
Ogawa, K; Suzuki, M | 1 |
Anders, JC; Crisona, FJ; Hamrick, ME | 1 |
Lloveres, J; Pérez Fontán, J; Tato, F | 1 |
Bharani, A; Bhargava, KD; Ganguly, A | 1 |
Calderón, RB; de Macedo, IL | 1 |
Barrera Ruiz, ML; Castillo Camacho, JA; Descalzo Señorans, A; González Barrero, A; Sáez Ariza, C; Santos de Soto, J | 1 |
Ghali, JK; Graves, SW; Liendo, C | 1 |
Ohta, H | 1 |
Higuchi, S; Minemoto, M; Suematsu, F; Yukawa, E | 1 |
Eber, B; Emmanuilidis, K; Müller, C; Steimer, W | 1 |
Fernandez, HM; Leipzig, RM | 1 |
Young, J | 1 |
Moore, CK | 1 |
Barbour, MM; Zuwallack, A | 1 |
Parmley, WW | 1 |
Goto, Y; Higuchi, S; Minemoto, M; Ohdo, S; Suematsu, F; Yukawa, E; Yukawa, M | 2 |
Agustí Escasany, A; Arnau De Bolós, JM; Casas Rodríguez, J; Diogène Fadini, E; Durán Dalmau, M; Galve Basilio, E; Manito Lorite, N; Rodríguez Cumplido, D | 1 |
Clark, A; Cleland, JG; Dhawan, J; John, J | 1 |
Eber, B; Müller, C; Steimer, W | 1 |
Dasgupta, A | 1 |
Dasgupta, A; Datta, P; Saffer, H; Wells, A | 1 |
McKelvie, R | 4 |
Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Suzuki, T; Takayama, Y; Toyama, T | 1 |
Gould, PA; Kaye, DM | 1 |
Barclay, M; Florkowski, C; Howard, G; Moore, G; Roche, A | 1 |
Amasaki, H; Hirose, H; Machida, N; Nakagawa, K; Takemura, N; Washizu, M | 1 |
Dasgupta, A; Datta, P | 1 |
Steimer, W | 1 |
Denvir, MA; LeMaitre, JP; Leslie, SJ; McKee, SP; Webb, DJ | 1 |
DE GRAEFF, J; LAMEIJER, LD | 1 |
Taylor, AL | 1 |
Gaulden, L | 1 |
Cowley, AJ; McKenzie, DB | 1 |
Klues, HG; Martin, N; Ott, R | 1 |
Pitt, B | 1 |
Conthe, P; Forteza-Rey, J; García-Alegría, J; Montero, M; Montoto, C; Román-Sánchez, P | 1 |
Haaijer-Ruskamp, FM; Jaarsma, T; Sturm, H; Van Veldhuisen, DJ | 1 |
Cox, JL; Humphries, K; Lee, DS; Pilote, L; Ramer, SA; Svenson, L; Tu, JV | 1 |
Hervas-Malo, M; Jacobs, P; Nilsson, C; Shibata, MC; Tsuyuki, RT | 1 |
Arana, MC; Bengochea, LA; Catania, VA; Delli Carpini, G; Ghanem, CI; Gómez, PC; Luquita, MG; Mottino, AD; Perassolo, M; Veggi, LM | 1 |
Bolling, SF; Geltz, A; Spoor, MT | 1 |
Dasgupta, A; Datta, P; Kang, E | 1 |
Ezekowitz, JA; Lee, DS; McAlister, FA; Newman, AM; Tu, JV | 1 |
Cordina, J; Norris, CA; Ogundipe, OA | 1 |
Dasgupta, A; Tso, G; Wells, A | 1 |
Altenberger, H; Finsterer, J; Stöllberger, C | 1 |
Ceri, O; Koçak, OM; Soykan, A; Tatlidil, E; Yilmaz, A | 1 |
Mehta, S; Vijayakumar, M | 1 |
Hayashi, T; Iguchi, K; Ijiri, Y; Kanada, Y; Kato, R; Murakami, S; Nishihara, M; Suzuki, K; Tamai, H; Tanaka, K; Yamada, T | 1 |
Akchurin, RS; Chernova, NA; Erastova, NV; Grishin, IR; Karpov, IuA; Latypov, RS; Lopukhova, VV; Mareev, IuV; Saidova, MA; Sapel'nikov, OV | 1 |
Armbruster, D; Cooper, KC; Dasgupta, A; DeFrance, A; Petty, D | 1 |
Dasgupta, A; Johnson, MJ | 1 |
Büller, HR; de Boer, A; de Peuter, OR; Kamphuisen, PW; Klungel, OH; Lip, GY; Souverein, PC | 1 |
Alabd, A; Gamal, A; Rayan, M; Tawfik, M | 1 |
Biggar, RJ | 1 |
Dasgupta, A; Johnson, MJ; Sengupta, TK | 1 |
Hamed, SS; Volpe, DA; Zhang, LK | 1 |
Haythe, J; Lewey, J | 1 |
Agra, Y; Moreno-Gómez, AM; Otero, MJ; Santos-Ramos, B | 1 |
Eurich, DT; McAlister, FA; Murphy, GK | 1 |
Getachew, H; Shibeshi, W; Tadesse, Y | 1 |
Malebranche, R; Morisset, PH; Raphael, NA; Tabou Moyo, C; Wilentz, JR | 1 |
Baez, A; Bazán, C; Camino Willhuber, GO; Fretes, R; Guzman Mentesana, G; Lo Presti, S; Paglini-Oliva, PA; Rivarola, HW; Strauss, M | 1 |
Franken, PR; Woltersdorf, R | 1 |
Abdel Jalil, MH; Abdullah, N; Abu-Hammour, K; Alsous, MM; Saleh, M | 1 |
Du, P; Jia, A; Li, X; Li, Y; Ma, Y; Wang, A | 2 |
Dizaye, KF; Z Rashid, B | 1 |
21 review(s) available for spironolactone and digoxin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Variability in response to drugs.
Topics: Acute Disease; Acylation; Chlorthalidone; Chronic Disease; Depression; Diazoxide; Digoxin; Dose-Response Relationship, Drug; Glomerulonephritis; Humans; Hypertension; Nephrotic Syndrome; Norepinephrine; Nortriptyline; Oxidation-Reduction; Phenylthiourea; Serotonin; Spironolactone; Steroids | 1974 |
[The importance of the biliary excretion of drugs in the human].
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bile; Biological Transport; Cardiac Glycosides; Contraceptives, Oral, Hormonal; Diazepam; Digoxin; Enterohepatic Circulation; Fluorenes; Half-Life; Hexamethonium Compounds; Humans; Imipramine; Indocyanine Green; Kidney Diseases; Liver Diseases; Molecular Weight; Pharmaceutical Preparations; Spironolactone | 1983 |
[Clinical pharmacology of digitalis glycosides].
Topics: Digitalis Glycosides; Digitoxin; Digoxin; Drug Interactions; Furosemide; Humans; Kinetics; Quinidine; Spironolactone; Vasodilator Agents | 1982 |
The interaction of spironolactone and digoxin: a review and evaluation.
Topics: Digoxin; Drug Interactions; Humans; Kinetics; Radioimmunoassay; Spironolactone | 1981 |
Pharmacotherapy of systolic heart failure: emphasis on mortality outcomes.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Digoxin; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Spironolactone; Survival Analysis | 2001 |
[Evidence based medical treatment of heart failure].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Anticoagulants; Calcium Channel Blockers; Cardiotonic Agents; Cost-Benefit Analysis; Digoxin; Diuretics; Evidence-Based Medicine; Heart Failure; Humans; Spironolactone; Vasodilator Agents | 2001 |
What is the optimal medical management of ischaemic heart failure?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cardiotonic Agents; Digoxin; Diuretics; Heart Failure; Humans; Hypolipidemic Agents; Myocardial Ischemia; Myocardial Revascularization; Nitrates; Patient Selection; Smoking Cessation; Spironolactone; Thrombolytic Therapy | 2001 |
Endogenous and exogenous digoxin-like immunoreactive substances: impact on therapeutic drug monitoring of digoxin.
Topics: Cardenolides; Cross Reactions; Digoxin; Drug Monitoring; Drugs, Chinese Herbal; Humans; Immunoassay; Saponins; Spironolactone | 2002 |
Heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Combined Modality Therapy; Defibrillators, Implantable; Digoxin; Exercise; Heart Failure; Humans; Patient Care Team; Randomized Controlled Trials as Topic; Spironolactone; Survival Rate; Treatment Outcome | 2002 |
Clinical treatment regimens for chronic heart failure: a review.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cardiotonic Agents; Digoxin; Diuretics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Pacemaker, Artificial; Spironolactone; Vasodilator Agents | 2002 |
Heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Combined Modality Therapy; Defibrillators, Implantable; Digoxin; Exercise; Heart Failure; Humans; Spironolactone | 2002 |
Diagnosis and management of heart failure in the long-term care setting.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Chronic Disease; Digoxin; Diuretics; Drug Interactions; Echocardiography; Heart Failure; Humans; Long-Term Care; Receptors, Angiotensin; Spironolactone | 2003 |
Drug therapy in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cardiovascular Agents; Chronic Disease; Digoxin; Diuretics; Female; Heart Failure; Humans; Male; Middle Aged; Spironolactone; Vasodilator Agents | 2003 |
Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Digoxin; Enzyme Inhibitors; Eplerenone; Female; Humans; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Randomized Controlled Trials as Topic; Spironolactone; Systole; Ventricular Dysfunction, Left | 2004 |
Heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Defibrillators, Implantable; Digoxin; Exercise; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Platelet Aggregation Inhibitors; Spironolactone; Warfarin | 2004 |
Management of heart failure in The Netherlands.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiology; Digoxin; Diuretics; Family Practice; Heart Failure; Humans; Incidence; Netherlands; Practice Guidelines as Topic; Prevalence; Spironolactone | 2005 |
Heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Cardiotonic Agents; Defibrillators, Implantable; Digoxin; Exercise; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Platelet Aggregation Inhibitors; Spironolactone; Warfarin | 2004 |
Molecular pathways: digoxin use and estrogen-sensitive cancers--risks and possible therapeutic implications.
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Digoxin; Estrogens; Female; Humans; Male; Neoplasms, Hormone-Dependent; Phytoestrogens; Receptors, Estrogen; Risk Factors; Selective Estrogen Receptor Modulators; Spironolactone; Tamoxifen; Uterine Neoplasms | 2012 |
Cardiomyopathy in pregnancy.
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia, Obstetrical; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Cardiomyopathies; Contraindications; Digoxin; Diuretics; Female; Heart Failure; Humans; Incidence; Infant, Newborn; Maternal Age; Maternal Mortality; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Pregnancy, High-Risk; Prognosis; Risk Factors; Spironolactone; Treatment Outcome | 2014 |
A systematic review of population pharmacokinetic analyses of digoxin in the paediatric population.
Topics: Child; Digoxin; Heart Failure; Humans; Infant; Infant, Newborn; Models, Biological; Nonlinear Dynamics; Pediatrics; Spironolactone | 2020 |
8 trial(s) available for spironolactone and digoxin
Article | Year |
---|---|
The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide.
Topics: Adult; Bendroflumethiazide; Benzoates; Butylamines; Chlorides; Clinical Trials as Topic; Coronary Disease; Creatine; Digoxin; Diuretics; Drug Synergism; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Natriuresis; Nephrons; Placebos; Potassium; Potassium Chloride; Sodium; Spironolactone; Sulfonamides | 1975 |
Digoxin-interactions in man: spironolactone reduces renal but not biliary digoxin clearance.
Topics: Adult; Bile; Digoxin; Drug Interactions; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Spironolactone | 1992 |
Potassium-sparing diuretics: interaction with digoxin in elderly men.
Topics: Aged; Clinical Trials as Topic; Digoxin; Diuretics; Drug Interactions; Erythrocytes; Female; Furosemide; Humans; Hydrochlorothiazide; Male; Middle Aged; Potassium; Spironolactone; Triamterene | 1984 |
Spironolactone therapy in infants with congestive heart failure secondary to congenital heart disease.
Topics: Chlorothiazide; Clinical Trials as Topic; Digoxin; Drug Therapy, Combination; Female; Heart Defects, Congenital; Heart Failure; Humans; Infant; Male; Potassium; Random Allocation; Spironolactone | 1981 |
Systolic time intervals during spironolactone treatment of digitalized and non-digitalized patients with ischaemic heart disease.
Topics: Aged; Blood Pressure; Body Weight; Coronary Disease; Depression, Chemical; Digoxin; Drug Interactions; Humans; Middle Aged; Myocardial Contraction; Potassium; Spironolactone; Systole | 1982 |
Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Chemotherapy, Adjuvant; Chronic Disease; Coronary Disease; Cross-Over Studies; Digoxin; Double-Blind Method; Female; Furosemide; Heart Failure; Heart Function Tests; Humans; Hypertension; India; Male; Middle Aged; Plants, Medicinal; Quality of Life; Spironolactone; Treatment Outcome; Ventricular Function, Left; Weight Loss | 1995 |
Spironolactone improves cardiac sympathetic nerve activity and symptoms in patients with congestive heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Drug Therapy, Combination; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Radionuclide Imaging; Radiopharmaceuticals; Spironolactone; Stroke Volume; Sympathetic Nervous System | 2002 |
Ivabradine, a novel heart rate slower: is it a sword of double blades in patients with idiopathic dilated cardiomyopathy?
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Benzazepines; Carbazoles; Cardiomyopathy, Dilated; Cardiotonic Agents; Carvedilol; Digoxin; Diuretics; Drug Therapy, Combination; Echocardiography; Electrocardiography; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Propanolamines; Prospective Studies; Spironolactone; Vasodilator Agents; Ventricular Premature Complexes | 2011 |
137 other study(ies) available for spironolactone and digoxin
Article | Year |
---|---|
Cloning and functional characterization of a new multispecific organic anion transporter, OAT-K2, in rat kidney.
Topics: Amino Acid Sequence; Animals; Base Sequence; Carrier Proteins; Cloning, Molecular; DNA, Complementary; Kidney; Male; Membrane Proteins; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Oocytes; Organic Anion Transporters; Rats; Rats, Wistar; RNA, Messenger; Sequence Homology, Amino Acid; Sequence Homology, Nucleic Acid; Tissue Distribution; Transfection; Xenopus laevis | 1999 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Changes in crystallinity and solubility on comminution of digoxin and observations on spironolactone and oestradiol.
Topics: Chemistry, Pharmaceutical; Crystallization; Differential Thermal Analysis; Digoxin; Estradiol; Microscopy, Electron, Scanning; Particle Size; Powders; Solubility; Spectrophotometry, Infrared; Spironolactone; X-Ray Diffraction | 1976 |
Interaction of spironolactone and digoxin in dogs.
Topics: Adenosine Triphosphatases; Animals; Arrhythmias, Cardiac; Biological Availability; Blood Pressure; Digoxin; Dogs; Drug Interactions; Female; In Vitro Techniques; Male; Membranes; Myocardial Contraction; Myocardium; Potassium; Sodium; Spironolactone | 1977 |
Interaction of spironolactone and digitalis with the 5 alpha-dihydrotestosterone (DHT) receptor of rat ventral prostate.
Topics: Animals; Binding Sites; Cytosol; Digitalis Glycosides; Digitoxin; Digoxin; Dihydrotestosterone; Male; Prostate; Rats; Receptors, Cell Surface; Spironolactone | 1975 |
A critical appraisal of a further three new commercial digoxin radioimmunoassay kits with reference to cross-reacting substances.
Topics: Blood Proteins; Canrenone; Cross Reactions; Digitoxin; Digoxin; Evaluation Studies as Topic; Furosemide; Humans; Radioimmunoassay; Reagent Kits, Diagnostic; Spironolactone | 1979 |
Relationship between dose and plasma level of digoxin and patient characteristics.
Topics: Adult; Aged; Digoxin; Dose-Response Relationship, Drug; Female; Humans; Kidney Function Tests; Male; Middle Aged; Spironolactone | 1979 |
Painful gynaecomastia treated with tamoxifen.
Topics: Aged; Bronchial Neoplasms; Digoxin; Gynecomastia; Humans; Male; Middle Aged; Spironolactone; Tamoxifen | 1979 |
Life threatening drug reactions amongst medical in-patients.
Topics: Aged; Arrhythmias, Cardiac; Bethanidine; Digoxin; Drug-Related Side Effects and Adverse Reactions; Female; Furosemide; Humans; Hyperkalemia; Hypotension, Orthostatic; Male; Middle Aged; Spironolactone; Uremia | 1979 |
The effect of oral spironolactone and intravenous canrenoate-K on the digoxin radioimmunoassay.
Topics: Canrenoic Acid; Digoxin; Drug Interactions; Humans; Pregnadienes; Radioimmunoassay; Spironolactone; Time Factors | 1977 |
Cross reactivity of digitoxin and spironolactone in two radioimmunoassays for serum digoxin.
Topics: Cross Reactions; Digitalis Glycosides; Digitonin; Digoxin; Evaluation Studies as Topic; Humans; Male; Methods; Radioimmunoassay; Spironolactone | 1978 |
Spironolactone-induced changes in digoxin kinetics.
Topics: Adult; Aged; Digoxin; Drug Interactions; Half-Life; Humans; Kinetics; Middle Aged; Models, Biological; Spironolactone; Time Factors | 1978 |
[The pharmacokinetics of digoxin during chronic spironolacton treatment (author's transl)].
Topics: Adult; Aged; Antipyrine; Digoxin; Feces; Female; Half-Life; Heart Failure; Humans; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Spironolactone | 1978 |
Plasma digoxin radioimmunoassay in patients treated with potassium canrenoate and spironolactone. A comparison of two commerical kits.
Topics: Adult; Aged; Canrenoic Acid; Digoxin; Female; Humans; Male; Middle Aged; Pregnadienes; Radioimmunoassay; Reagent Kits, Diagnostic; Spironolactone | 1978 |
Spironolactone-associated digoxin radioimmunoassay interference.
Topics: Digoxin; Humans; Iodine Radioisotopes; Male; Radioimmunoassay; Spironolactone; Tritium | 1979 |
[Clinically significant cross reactions in radioimmunological determination of digoxin].
Topics: Adult; Antigen-Antibody Reactions; Cross Reactions; Digoxin; False Positive Reactions; Female; Humans; Lanatosides; Male; Pregnancy; Radioimmunoassay; Spironolactone; Strophanthins; Triamterene | 1977 |
[Plasma-digoxin concentration in patients at time of hospital admission (author's transl)].
Topics: Ambulatory Care; Canrenoic Acid; Creatinine; Digitalis Glycosides; Digoxin; Female; Hospitalization; Humans; Male; Radioimmunoassay; Spironolactone | 1977 |
Some factors affecting a commercial kit for radioimmunoassay of digoxin using tritiated digoxin.
Topics: Amniotic Fluid; Chemical Phenomena; Chemistry; Cross Reactions; Digitoxin; Digoxin; Ethanol; Female; Fetal Blood; Humans; Male; Polygeline; Pregnancy; Radioimmunoassay; Spironolactone | 1977 |
The influence of therapeutic doses of spironolactone on the liver microsomal enzyme system and digoxin elimination in man [proceedings].
Topics: Digoxin; Humans; Microsomes, Liver; Spironolactone | 1977 |
[Determination of serum digoxin: a path to better control of therapy?].
Topics: Arrhythmias, Cardiac; Digitalis Glycosides; Digoxin; Drug Interactions; Humans; Spironolactone | 1977 |
Effects of pretreatment with spironolactone of pharmacokinetics of 4'''-methyldigoxin in man.
Topics: Administration, Oral; Adult; Bile; Canrenoic Acid; Canrenone; Digoxin; Feces; Female; Half-Life; Humans; Injections, Intravenous; Kinetics; Male; Middle Aged; Spironolactone; Tritium | 1976 |
Effect of potassium-sparing diuretics on the renin-angiotensin-aldosterone system and potassium retention in heart failure.
Topics: Adult; Aged; Aldosterone; Amiloride; Angiotensin II; Digoxin; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Potassium; Renin; Sodium; Spironolactone; Urea | 1976 |
Different effects of microsomal enzyme inducers on the biliary excretion of digoxin.
Topics: Animals; Benzopyrenes; Bile; Digoxin; Enzyme Induction; Liver; Male; Microsomes, Liver; Perfusion; Phenobarbital; Rats; Spironolactone | 1976 |
Influence of spironolactone pretreatment on pharmacokinetics and metabolism of digitoxin in rats.
Topics: Animals; Chloroform; Chromatography, Thin Layer; Digitoxigenin; Digitoxin; Digoxin; Drug Interactions; Female; Glucuronates; Half-Life; Hydroxylation; Kinetics; Liver; Rats; Solubility; Spironolactone; Tritium | 1975 |
[Simplified rapid determination of plasma digoxin. Methods and clinical evaluation].
Topics: Anuria; Binding Sites, Antibody; Digoxin; Drug Tolerance; False Positive Reactions; Humans; Iodine Radioisotopes; Potassium; Radioimmunoassay; Renal Dialysis; Spironolactone; Tachycardia; Time Factors; Tritium | 1975 |
Negligible interference by spironolactone and prednisone in digoxin radioimmunoassay.
Topics: Digoxin; Evaluation Studies as Topic; Humans; Prednisone; Radioimmunoassay; Spironolactone | 1975 |
Changes in the plasma levels and basic pharmacokinetic parameters of digoxin used in combination with gentamicin, amiodarone and spironolactone.
Topics: Amiodarone; Animals; Digoxin; Drug Interactions; Gentamicins; Half-Life; Male; Rabbits; Spironolactone | 1992 |
Inhibition by basic drugs of digoxin secretion into human bile.
Topics: Bile; Chromatography, High Pressure Liquid; Digoxin; Drug Interactions; Humans; Probenecid; Quinidine; Quinine; Radioimmunoassay; Spironolactone; Verapamil | 1992 |
Influence of spironolactone and its metabolite canrenone on serum digoxin assays.
Topics: Canrenone; Cross Reactions; Digoxin; Half-Life; Humans; Iodine Radioisotopes; Pregnadienes; Radioimmunoassay; Spironolactone | 1990 |
Concentrative uptake of digoxin by slices of chicken renal cortex.
Topics: Animals; Chickens; Digitoxin; Digoxigenin; Digoxin; Female; Hexoses; Kidney Cortex; Kinetics; Ouabain; Potassium; Probenecid; Quinine; Sodium Cyanide; Spironolactone | 1990 |
A dry-strip immunometric assay for digoxin on the Ames Seralyzer.
Topics: Antibody Specificity; Bilirubin; Biotransformation; Cross Reactions; Digoxin; Evaluation Studies as Topic; Hemoglobins; Humans; Reagent Kits, Diagnostic; Spironolactone | 1990 |
Reassessment of cross-reactivity of spironolactone metabolites with four digoxin immunoassays.
Topics: Adult; Canrenone; Cross Reactions; Digoxin; Humans; Immunoassay; Immunoenzyme Techniques; Male; Radioimmunoassay; Spironolactone | 1989 |
Interference of spironolactone metabolites in a digoxin radioimmunoassay.
Topics: Digoxin; Humans; Radioimmunoassay; Spironolactone | 1989 |
The effect of renal and hepatic impairment and of spironolactone on digoxin immunoassays.
Topics: Aged; Aged, 80 and over; Digoxin; Female; Humans; Immunoassay; Kidney Diseases; Liver Diseases; Male; Middle Aged; Spironolactone | 1988 |
Spironolactone as a source of interference in commercial digoxin immunoassays.
Topics: Adult; Aged; Cross Reactions; Digoxin; Female; Humans; Male; Middle Aged; Radioimmunoassay; Spironolactone | 1987 |
Interaction between digoxin and commonly coadministered drugs in children.
Topics: Amiodarone; Child, Preschool; Digoxin; Drug Interactions; Drug Therapy, Combination; Humans; Infant; Infant, Newborn; Nifedipine; Quinidine; Spironolactone; Verapamil | 1985 |
Effect of spironolactone on the renal clearance of digoxin in dogs.
Topics: Aldosterone; Animals; Digoxin; Dogs; Inulin; Kidney; Metabolic Clearance Rate; Potassium; Quinidine; Sodium; Spironolactone | 1985 |
Biological availability of drugs.
Topics: Biopharmaceutics; Chloramphenicol; Digoxin; Griseofulvin; Oxytetracycline; Phenindione; Spironolactone | 1972 |
Effects of pretreatment with spironolactone on pharmacokinetics of 4'''-methyldigoxin in rats.
Topics: Animals; Bile; Dealkylation; Digoxin; Duodenum; Female; Half-Life; Injections; Liver; Rats; Spironolactone; Time Factors; Tritium | 1973 |
Extrarenal actions of aldosterone antagonists in guinea pigs. II. Reduction of the toxicity of beta-methyl-digoxin.
Topics: Animals; Digoxin; Drug Interactions; Female; Guinea Pigs; Heart; In Vitro Techniques; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Spironolactone; Tritium | 1973 |
Proceedings: The influence of spironolactone on the excretion and metabolism of 3H-digoxin in the rat.
Topics: Animals; Cardanolides; Chromatography, Paper; Chromatography, Thin Layer; Digoxin; Feces; Female; Male; Rats; Spironolactone; Stimulation, Chemical; Tritium | 1974 |
Effect of microsomal enzyme inducers on the biliary excretion of cardiac glycosides.
Topics: Analysis of Variance; Animals; Bile; Biotransformation; Cardiac Glycosides; Digitoxin; Digoxin; Dose-Response Relationship, Drug; Enzyme Induction; Lethal Dose 50; Liver; Male; Methylcholanthrene; Microsomes; Myocardium; Organ Size; Ouabain; Paralysis; Phenobarbital; Pregnenolone Carbonitrile; Rats; Spironolactone; Time Factors; Tritium; Zoxazolamine | 1974 |
[Proceedings: Effect of potassium canrenoate (aldactone pro inj.) and digoxin on hemodynamics and infarct size in experimental myocardial infarct].
Topics: Animals; Blood Pressure; Cardiac Output; Digoxin; Dogs; Electrocardiography; Myocardial Infarction; Spironolactone | 1974 |
Chronic vasodilator therapy in the management of cardiogenic shock and intractable left ventricular failure.
Topics: Blood Pressure; Cardiac Output; Digoxin; Drug Evaluation; Ferricyanides; Furosemide; Heart Failure; Humans; Infusions, Parenteral; Isosorbide Dinitrate; Male; Middle Aged; Nitric Oxide; Pulmonary Circulation; Shock, Cardiogenic; Spironolactone; Vasodilator Agents | 1974 |
Effect of spironolactone on excretion of 3H-digoxin and its metabolites in rats.
Topics: Animals; Chloroform; Chromatography, Paper; Chromatography, Thin Layer; Digitoxigenin; Digoxin; Enzyme Induction; Feces; Female; Microsomes, Liver; Rats; Spironolactone; Time Factors; Tritium | 1974 |
Heart failure and cardiac arrhythmias.
Topics: Arrhythmia, Sinus; Arrhythmias, Cardiac; Coronary Disease; Digoxin; Diuretics; Electroconvulsive Therapy; Endocarditis, Bacterial; Heart Aneurysm; Heart Failure; Heart Valve Diseases; Heart Ventricles; Humans; Lidocaine; Myocardial Infarction; Pacemaker, Artificial; Pericarditis, Constrictive; Potassium Deficiency; Rupture; Spironolactone; Tachycardia; Ventricular Fibrillation; Wolff-Parkinson-White Syndrome | 1974 |
The effect of spironolactone and canrenone on the digoxin radioimmunoassay.
Topics: Animals; Antigen-Antibody Complex; Ascites; Charcoal; Digoxin; Half-Life; Humans; Immune Sera; Ketosteroids; Lactones; Pregnadienes; Rabbits; Radioimmunoassay; Sheep; Spironolactone; Tritium | 1974 |
The improvement of specificity in radioimmunoassays.
Topics: Adsorption; Androstenes; Antigen-Antibody Complex; Cardanolides; Digitoxin; Digoxin; Immune Sera; Ketosteroids; Kinetics; Methods; Prednisolone; Prednisone; Radioimmunoassay; Spironolactone; Tritium | 1973 |
Generic non-equivalence in cardiac practice.
Topics: Anticoagulants; Digoxin; Heart Diseases; Humans; Spironolactone; Therapeutic Equivalency | 1973 |
[Clinical study on the subtoxic full effective and maintenance dose of digoxin under the influence of spironolactone. Studies on the decompensated heart patient].
Topics: Administration, Oral; Aged; Digoxin; Drug Tolerance; Female; Heart Failure; Humans; Magnesium; Male; Middle Aged; Potassium; Spironolactone | 1973 |
H3-digitoxin and its metabolites following spironolactone pretreatment of rats.
Topics: Animals; Bile; Digitoxin; Digoxin; Feces; Liver; Male; Rats; Spironolactone; Tritium | 1973 |
Muscle electrolytes and total exchangeable electrolytes in patients with cardiac diseases.
Topics: Adult; Age Factors; Aortic Valve Stenosis; Body Water; Chlorides; Cytoplasm; Digoxin; Diuretics; Extracellular Space; Female; Heart Valve Diseases; Humans; Magnesium; Male; Middle Aged; Mitral Valve Stenosis; Muscles; Potassium; Radioisotopes; Sex Factors; Sodium; Spironolactone; Water-Electrolyte Balance | 1973 |
Salivary electrolytes in digitalis-treated patients with and without raised aldosterone excretion.
Topics: Adult; Aged; Aldosterone; Calcium; Digoxin; Female; Heart Failure; Humans; Male; Middle Aged; Potassium; Radioimmunoassay; Saliva; Sodium; Spironolactone | 1973 |
[Clinical experiences with the determination of the plasma digoxin level].
Topics: Amniotic Fluid; Blood; Digoxin; False Positive Reactions; Female; Humans; Maternal-Fetal Exchange; Pregnancy; Radioimmunoassay; Spironolactone; Tritium; Umbilical Cord | 1973 |
Renal tubular secretion of digoxin.
Topics: Adult; Aged; Digoxin; Female; Glomerular Filtration Rate; Heart Failure; Humans; Inulin; Kidney Tubules; Kidney Tubules, Distal; Male; Middle Aged; Protein Binding; Spironolactone | 1974 |
[Digoxin incorporation into the cell].
Topics: Aldosterone; Animals; Biological Transport; Carcinoma, Ehrlich Tumor; Digitoxin; Digoxin; In Vitro Techniques; Mice; Prednisolone; Spironolactone; Thyroid Hormones; Tritium | 1971 |
[Effect of aldactone on the dynamics and contractility of the heart].
Topics: Cardiac Catheterization; Digoxin; Heart; Hemodynamics; Humans; Mineralocorticoid Receptor Antagonists; Muscle Contraction; Spironolactone | 1971 |
Effect of spironolactone and norbolethone on the toxicity of digitalis compounds in the rat.
Topics: Anabolic Agents; Animals; Cardanolides; Cardiac Glycosides; Digitalis Glycosides; Digitoxin; Digoxin; Female; Ouabain; Rats; Spironolactone; Strophanthins | 1969 |
Heart failure. II.
Topics: Aged; Aortic Valve Insufficiency; Digitoxin; Digoxin; Ethacrynic Acid; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Oxygen Inhalation Therapy; Pulmonary Heart Disease; Spironolactone | 1971 |
[Clinical experience with a new spironolactone-thiabuzide combination].
Topics: Aged; Body Weight; Digoxin; Diuretics; Drug Synergism; Edema; Female; Furosemide; Glycosuria; Humans; Hypertension; Male; Middle Aged; Natriuresis; Potassium; Spironolactone; Strophanthins; Tolbutamide | 1968 |
[The effects of digoxin, desoxycorticosterone and spironolactone on the myocardium of the mammal].
Topics: Animals; Calcium; Desoxycorticosterone; Digoxin; Drug Synergism; Guinea Pigs; Heart; Heart Atria; Potassium; Sodium; Spironolactone | 1967 |
Failure of the aldosterone antagonist spironolactone to inhibit myocardial hypertrophy produced by experimental hyperthyroidism and accompanied by "apparent" digoxin immunoreactivity in the blood.
Topics: Animals; Antigen-Antibody Reactions; Cardiomegaly; Digoxin; Heart; Hyperthyroidism; Male; Organ Size; Rats; Spironolactone; Thyroxine | 1980 |
Congestive heart failure due to giant cutaneous cavernous hemangioma.
Topics: Digoxin; Drug Resistance; Facial Neoplasms; Female; Furosemide; Heart Failure; Hemangioma, Cavernous; Humans; Infant; Spironolactone | 1984 |
[Heart failure therapy with digitalis and spironolactone--studies within the scope of preoperative treatment before lung resection].
Topics: Adult; Aged; Digitalis Glycosides; Digoxin; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Lung Neoplasms; Male; Medigoxin; Middle Aged; Premedication; Spironolactone | 1984 |
Spironolactone-digoxin interaction.
Topics: Adult; Aged; Digoxin; Drug Interactions; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Spironolactone | 1983 |
Influence of spironolactone on serum digoxin concentration.
Topics: Aged; Digoxin; Drug Interactions; Female; Humans; Spironolactone | 1984 |
Digoxin-quinidine-spironolactone interaction.
Topics: Adult; Creatinine; Digoxin; Drug Interactions; Female; Half-Life; Humans; Kinetics; Male; Middle Aged; Quinidine; Spironolactone | 1984 |
Interactions between digoxin and potassium-sparing diuretics.
Topics: Adult; Digoxin; Drug Interactions; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; Kinetics; Male; Muscle Contraction; Spironolactone; Triamterene | 1983 |
Drugs that increase the serum concentration of digoxin.
Topics: Anti-Bacterial Agents; Calcium Channel Blockers; Digoxin; Drug Interactions; Humans; Quinidine; Quinine; Spironolactone | 1983 |
Beta-blockers in dilated cardiomyopathies: they work.
Topics: Administration, Oral; Adult; Aged; Digoxin; Dilatation, Pathologic; Drug Therapy, Combination; Female; Follow-Up Studies; Furosemide; Heart Failure; Hemodynamics; Humans; Lactates; Male; Metoprolol; Middle Aged; Myocardium; Oxygen Consumption; Propanolamines; Spironolactone; Time Factors | 1983 |
Pediatric clinical pharmacology of digoxin.
Topics: Adult; Child; Digoxin; Diuretics; Drug Interactions; Furosemide; Heart; Heart Diseases; Hemoperfusion; Humans; Infant; Infant, Newborn; Male; Myocardium; Oxygen Consumption; Quinidine; Spironolactone | 1981 |
Spironolactone interference with digoxin radioimmunoassay in cirrhotic patients.
Topics: Digoxin; Drug Interactions; Humans; Liver Cirrhosis; Radioimmunoassay; Serum Albumin; Spironolactone | 1980 |
Comparison of methods for estimating digoxin dosing regimens: further analysis.
Topics: Adult; Aged; Aging; Creatinine; Digoxin; Female; Humans; Kidney; Male; Middle Aged; Spironolactone | 1981 |
Precision of digoxin radioimmunoassays and matrix effects: four kits compared.
Topics: Digoxin; False Positive Reactions; Humans; Hypertension; Myocardial Infarction; Radioimmunoassay; Reagent Kits, Diagnostic; Spironolactone; Uremia | 1981 |
[Correlation of digoxin levels in the myocardium, plasma and saliva in patients under chronic treatment].
Topics: Adult; Aged; Atrial Fibrillation; Diazepam; Digoxin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardium; Saliva; Spironolactone | 1981 |
Glucuronidation of digitalis glycosides by rat liver microsomes: stimulation by spironolactone and pregnenolone-16 alpha-carbonitrile.
Topics: Animals; Digitalis Glycosides; Digitoxin; Digoxigenin; Digoxin; Female; Glucuronates; In Vitro Techniques; Kinetics; Male; Microsomes, Liver; Pregnenolone Carbonitrile; Rats; Spironolactone; Stimulation, Chemical | 1980 |
Clinical studies on digoxin intoxication. I. Serum concentration of digoxin in the elderly and the effect of diuretics.
Topics: Adult; Age Factors; Aged; Blood Urea Nitrogen; Creatinine; Digoxin; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Furosemide; Heart Diseases; Humans; Male; Metabolic Clearance Rate; Middle Aged; Powders; Protein Binding; Spironolactone; Tablets | 1980 |
Alteration of digoxin toxicity by 6-hydroxydopamine and soironolactone.
Topics: Animals; Digoxin; Dogs; Drug Interactions; Female; Heart; Hemodynamics; Hydroxydopamines; Male; Myocardial Contraction; Spironolactone; Sympathetic Nervous System | 1980 |
[The effects of diphenylhydantoin and spironolactone on the digoxin pharmacokinetics in the rabbit (author's transl)].
Topics: Animals; Digoxin; Kinetics; Phenytoin; Rabbits; Radioimmunoassay; Spironolactone; Time Factors | 1980 |
[Nonimmune fetal edema].
Topics: Adult; Anemia, Macrocytic; Apgar Score; Cardiotonic Agents; Digoxin; Diuretics; Female; Humans; Hydrops Fetalis; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Hematologic; Spironolactone; Ultrasonography, Prenatal | 1995 |
[Restrictive myocardiopathy in children. A study of 4 patients].
Topics: Cardiomyopathy, Restrictive; Cardiotonic Agents; Child; Child, Preschool; Digoxin; Diuretics; Drug Therapy, Combination; Fatal Outcome; Female; Furosemide; Humans; Infant; Male; Spironolactone | 1996 |
A new interference in some digoxin assays: anti-murine heterophilic antibodies.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Cardenolides; Digoxin; Diuretics; Drug Interactions; Drug Therapy, Combination; False Positive Reactions; Humans; Immunoenzyme Techniques; Male; Middle Aged; Saponins; Spironolactone | 1996 |
[99mTc(V)-DMSA accumulation in gynecomastia].
Topics: Digoxin; Furosemide; Gynecomastia; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Spironolactone; Technetium Tc 99m Dimercaptosuccinic Acid | 1998 |
Drugs for chronic heart failure.
Topics: Adrenergic beta-Antagonists; Angioedema; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Chronic Disease; Digoxin; Diuretics; Dose-Response Relationship, Drug; Heart Failure; Humans; Hypokalemia; Hypotension; Spironolactone; Vasodilator Agents | 1999 |
Population analysis for the optimization of digoxin treatment in Japanese paediatric patients.
Topics: Age Factors; Body Weight; Cardiotonic Agents; Child; Child, Preschool; Digoxin; Drug Interactions; Female; Heart Failure; Humans; Infant; Infant, Newborn; Male; Sex Factors; Spironolactone | 1999 |
Intoxication due to negative canrenone interference in digoxin drug monitoring.
Topics: Aged; Canrenone; Digoxin; Drug Interactions; Drug Monitoring; Enzyme Multiplied Immunoassay Technique; Fatal Outcome; Humans; Male; Medication Errors; Multiple Organ Failure; Sepsis; Spironolactone | 1999 |
Spironolactone in patients with heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Drug Therapy, Combination; Furosemide; Heart Failure; Humans; Spironolactone | 2000 |
Heart failure: highlights from new consensus guidelines.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Digoxin; Diuretics; Echocardiography, Doppler; Heart Failure; Humans; Life Style; Mineralocorticoid Receptor Antagonists; Practice Guidelines as Topic; Spironolactone; Stroke Volume | 2000 |
Overview of current chronic heart failure therapy.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Heart Failure; Humans; Mississippi; Spironolactone; Stroke Volume | 2000 |
How many medicines do patients with heart failure need?
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cytokines; Digoxin; Disease Models, Animal; Diuretics; Endothelins; Etanercept; Heart Failure; Humans; Immunoglobulin G; Immunosuppressive Agents; Mice; Mice, Transgenic; Neprilysin; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Spironolactone; Tumor Necrosis Factor-alpha | 2001 |
Population-based investigation of relative clearance of digoxin in Japanese neonates and infants by multiple-trough screen analysis.
Topics: Cardiotonic Agents; Chi-Square Distribution; Digoxin; Diuretics; Drug Monitoring; Female; Humans; Infant; Infant, Newborn; Japan; Male; Models, Biological; Regression Analysis; Reproducibility of Results; Spironolactone | 2001 |
Digoxin assays: frequent, substantial, and potentially dangerous interference by spironolactone, canrenone, and other steroids.
Topics: Anti-Arrhythmia Agents; Canrenone; Chromatography, High Pressure Liquid; Cross Reactions; Digoxin; Diuretics; Drug Interactions; False Negative Reactions; Humans; Immunoenzyme Techniques; In Vitro Techniques; Mineralocorticoid Receptor Antagonists; Prodrugs; Reagent Kits, Diagnostic; Spironolactone | 2002 |
Bidirectional (positive/negative) interference of spironolactone, canrenone, and potassium canrenoate on serum digoxin measurement: elimination of interference by measuring free digoxin or using a chemiluminescent assay for digoxin.
Topics: Canrenoic Acid; Canrenone; Cardiotonic Agents; Digoxin; Drug Interactions; Fluorescence Polarization Immunoassay; Humans; Luminescent Measurements; Mineralocorticoid Receptor Antagonists; Reproducibility of Results; Spironolactone | 2002 |
Pharmacoepidemiologic detection of calcium channel blocker-induced change on digoxin clearance using multiple trough screen analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Calcium Channel Blockers; Creatinine; Digoxin; Diltiazem; Drug Interactions; Female; Heart Failure; Humans; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Models, Statistical; Nifedipine; Pharmacoepidemiology; Regression Analysis; Reproducibility of Results; Spironolactone; Verapamil | 2002 |
Lack of clinically significant interference by spironolactone with the AxSym Digoxin II assay.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Confidence Intervals; Digoxin; Female; Humans; Immunoenzyme Techniques; Male; Middle Aged; Spironolactone | 2003 |
Ebstein's anomaly in a beagle dog.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bundle-Branch Block; Cardiotonic Agents; Diagnosis, Differential; Diet, Sodium-Restricted; Digoxin; Diuretics; Dogs; Drug Therapy, Combination; Ebstein Anomaly; Echocardiography; Electrocardiography; Enalapril; Fatal Outcome; Furosemide; Isosorbide Dinitrate; Male; Spironolactone; Vasodilator Agents | 2003 |
A new turbidometric digoxin immunoassay on the ADVIA 1650 analyzer is free from interference by spironolactone, potassium canrenoate, and their common metabolite canrenone.
Topics: Canrenoic Acid; Canrenone; Cardiotonic Agents; Cross Reactions; Digoxin; Drug Interactions; Fluorescence Polarization Immunoassay; Humans; Spironolactone | 2003 |
"Lack of clinically significant interference by spironolactone with the Axsym Digoxin II assay" only applies to low-dose therapy with spironolactone.
Topics: Cardiotonic Agents; Cross Reactions; Digoxin; Dose-Response Relationship, Drug; Drug Interactions; Humans; Immunoenzyme Techniques; Mineralocorticoid Receptor Antagonists; Spironolactone | 2003 |
Management of chronic heart failure due to systolic left ventricular dysfunction by cardiologist and non-cardiologist physicians.
Topics: Aged; Cardiology; Chronic Disease; Digoxin; Diuretics; Female; Guideline Adherence; Heart Failure; Hospitalization; Humans; Male; Practice Guidelines as Topic; Practice Patterns, Physicians'; Spironolactone; Ventricular Dysfunction, Left | 2003 |
PERIODIC PARALYSIS.
Topics: Adolescent; Chlorides; Cortisone; Diet Therapy; Diet, Sodium-Restricted; Digoxin; Drug Therapy; Genetics, Medical; Glucose; Humans; Hypokalemia; Insulin; Paralyses, Familial Periodic; Paralysis; Periodicity; Phosphates; Potassium; Prednisone; Sodium; Sodium, Dietary; Spironolactone; Urine; Water-Electrolyte Balance | 1965 |
The African-American Heart Failure Trial (A-HeFT): rationale and methodology.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Black or African American; Digoxin; Diuretics; Drug Therapy, Combination; Ethnicity; Female; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Patient Selection; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Spironolactone; Ventricular Dysfunction, Left | 2003 |
[Idiopathic hypereosinophilia with cardiac involvement].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiomyopathy, Restrictive; Cardiotonic Agents; Diagnosis, Differential; Digoxin; Diuretics; Drug Therapy, Combination; Echocardiography, Doppler; Enalapril; Endomyocardial Fibrosis; Female; Humans; Hypereosinophilic Syndrome; Magnetic Resonance Imaging; Mineralocorticoid Receptor Antagonists; Mitral Valve Insufficiency; Patient Compliance; Prognosis; Spironolactone; Sulfonamides; Torsemide | 2004 |
Factors influencing medical treatment of heart failure patients in Spanish internal medicine departments: a national survey.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Cardiac Glycosides; Cardiotonic Agents; Cross-Sectional Studies; Digoxin; Diuretics; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Nitrates; Prospective Studies; Spironolactone | 2005 |
Pharmacological treatment of congestive heart failure in Canada: a description of care in five provinces.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Canada; Cardiotonic Agents; Digoxin; Diuretics; Drug Utilization; Heart Failure; Humans; Spironolactone | 2005 |
Economic implications of treatment guidelines for congestive heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Canada; Databases as Topic; Digoxin; Drug Costs; Drug Utilization Review; Guideline Adherence; Heart Failure; Hospital Costs; Hospitalization; Humans; Practice Guidelines as Topic; Spironolactone | 2005 |
Induction of rat intestinal P-glycoprotein by spironolactone and its effect on absorption of orally administered digoxin.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Digoxin; Drug Interactions; Intestinal Absorption; Intestinal Mucosa; Male; Rats; Rats, Wistar; Spironolactone | 2006 |
Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiomyopathy, Dilated; Combined Modality Therapy; Databases, Factual; Digoxin; Diuretics; Drug Therapy, Combination; Equipment Design; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Heart-Assist Devices; Humans; Male; Middle Aged; Milrinone; Mitral Valve; Mitral Valve Insufficiency; Norepinephrine; Pliability; Postoperative Complications; Prospective Studies; Recurrence; Reoperation; Spironolactone; Stroke Volume; Time Factors; Tricuspid Valve Insufficiency; Ultrasonography | 2006 |
A new enzyme-linked chemiluminescent immunosorbent digoxin assay is virtually free from interference of spironolactone, potassium canrenoate, and their common metabolite canrenone.
Topics: Artifacts; Canrenone; Cross Reactions; Digoxin; Enzyme-Linked Immunosorbent Assay; Fluorescence Polarization Immunoassay; Humans; Luminescent Measurements; Nephelometry and Turbidimetry; Reagent Kits, Diagnostic; Sensitivity and Specificity; Spironolactone | 2006 |
Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Digoxin; Diuretics; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Patient Readmission; Spironolactone; Stroke Volume; Time Factors; Treatment Outcome; Ultrasonography | 2008 |
Description of a chronic heart failure service model and review of pharmacotherapy in a district general hospital in comparison to Scottish Intercollegiate Guideline Network (SIGN) guidelines.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Digoxin; Disease Management; Diuretics; Heart Failure, Systolic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Medical Audit; Outpatient Clinics, Hospital; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prospective Studies; Retrospective Studies; Scotland; Spironolactone | 2008 |
Effect of spironolactone, potassium canrenoate and their common metabolite canrenone on serum digoxin measurement by digoxin III, a new digoxin immunoassay.
Topics: Canrenoic Acid; Canrenone; Cross Reactions; Digoxin; Drug Interactions; Humans; Immunoassay; Mineralocorticoid Receptor Antagonists; Spironolactone | 2008 |
Isolated left ventricular hypertrabeculation/noncompaction in a Turner mosaic with male phenotype.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiomyopathy, Dilated; Cardiotonic Agents; Carvedilol; Digoxin; Diuretics; Echocardiography; Furosemide; Heart Ventricles; Humans; Lisinopril; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Mosaicism; Phenotype; Propanolamines; Spironolactone; Turner Syndrome; Ventricular Dysfunction, Left | 2009 |
[A mourning case that referred with sexual identity disorder secondary to a general medical condition].
Topics: Bereavement; Depression; Digoxin; Erectile Dysfunction; Female; Gender Identity; Gynecomastia; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Spironolactone | 2009 |
Complications during enalapril and diuretic therapy for congestive cardiac failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Digoxin; Diuretics; Drug Therapy, Combination; Electrocardiography; Enalapril; Furosemide; Heart Failure; Humans; Infant; Male; Spironolactone | 2009 |
Interference between eplerenone and digoxin in fluorescence polarization immunoassay, microparticle enzyme immunoassay, and affinity column-mediated immunoassay.
Topics: Anti-Arrhythmia Agents; Antibodies; Cross Reactions; Digoxin; Eplerenone; Fluorescence Polarization Immunoassay; Humans; Immunoassay; In Vitro Techniques; Mineralocorticoid Receptor Antagonists; Spironolactone | 2010 |
[Application of cardiac resynchronization therapy and ivabradine in a patient with chronic heart failure].
Topics: Benzazepines; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiovascular Agents; Digoxin; Diuretics; Echocardiography; Electrocardiography; Furosemide; Heart Atria; Heart Failure; Heart Rate; Heart Ventricles; Humans; Ivabradine; Male; Middle Aged; Myocardial Infarction; Spironolactone; Treatment Outcome | 2010 |
Abbott ARCHITECT clinical chemistry and immunoassay systems: digoxin assays are free of interferences from spironolactone, potassium canrenoate, and their common metabolite canrenone.
Topics: Anti-Arrhythmia Agents; Canrenoic Acid; Canrenone; Chemistry, Clinical; Cross Reactions; Digoxin; Immunoassay; Mineralocorticoid Receptor Antagonists; Spironolactone | 2011 |
Effect of spironolactone, potassium canrenoate, and their common metabolite canrenone on Dimension Vista Digoxin Assay.
Topics: Biological Assay; Canrenoic Acid; Canrenone; Cardiotonic Agents; Chemistry, Clinical; Cross Reactions; Digoxin; Drug Interactions; Drug Monitoring; Humans; Immunoassay; Mineralocorticoid Receptor Antagonists; Osmolar Concentration; Reagent Kits, Diagnostic; Spironolactone | 2010 |
Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Digoxin; Diuretics; Female; Heart Failure; Hospitalization; Humans; Male; Myocardial Infarction; Myocardial Ischemia; Practice Patterns, Physicians'; Prognosis; Spironolactone; Stroke | 2011 |
Clinically insignificant negative interferences of spironolactone, potassium canrenoate, and their common metabolite canrenone in new dimension vista LOCI digoxin immunoassay.
Topics: Canrenoic Acid; Canrenone; Digoxin; Humans; Immunoassay; Luminescent Measurements; Models, Molecular; Spironolactone | 2012 |
Use of different parameters and equations for calculation of IC₅₀ values in efflux assays: potential sources of variability in IC₅₀ determination.
Topics: Algorithms; Caco-2 Cells; Cardiotonic Agents; Digoxin; Drug Interactions; Humans; Imidazoles; Inhibitory Concentration 50; Itraconazole; Piperazines; Spironolactone; Sulfones; Triazines; Vardenafil Dihydrochloride | 2014 |
Developing a list of high-alert medications for patients with chronic diseases.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Amiodarone; Analgesics, Opioid; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Cytostatic Agents; Digoxin; Dronedarone; Drug-Related Side Effects and Adverse Reactions; Eplerenone; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Insulin; Methotrexate; Mineralocorticoid Receptor Antagonists; Platelet Aggregation Inhibitors; Sodium Potassium Chloride Symporter Inhibitors; Spironolactone | 2014 |
Cardiovascular medication utilization and adherence among heart failure patients in rural and urban areas: a retrospective cohort study.
Topics: Adrenergic Antagonists; Aged; Aged, 80 and over; Canada; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Diuretics; Female; Follow-Up Studies; Heart Failure; Humans; Male; Medication Adherence; Renin-Angiotensin System; Retrospective Studies; Rural Population; Spironolactone; Treatment Outcome; Urban Population | 2015 |
Drug dosage adjustment in hospitalized patients with renal impairment at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Anti-Ulcer Agents; Antifungal Agents; Antihypertensive Agents; Ceftazidime; Cimetidine; Creatinine; Cross-Sectional Studies; Digoxin; Diuretics; Drug Dosage Calculations; Drug Prescriptions; Enalapril; Ethiopia; Female; Fluconazole; Gout Suppressants; Hospitalization; Humans; Male; Medication Errors; Middle Aged; Pharmaceutical Preparations; Prospective Studies; Renal Insufficiency, Chronic; Severity of Illness Index; Spironolactone; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Young Adult | 2015 |
Clinical and echocardiographic characteristics and outcomes in congestive heart failure at the Hospital of The State University of Haiti.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Age Distribution; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Carbazoles; Cardiomyopathy, Dilated; Cardiotonic Agents; Carvedilol; Cohort Studies; Digoxin; Diuretics; Echocardiography; Electrocardiography; Female; Furosemide; Haiti; Heart Failure; Hospitalization; Hospitals, University; Hospitals, Urban; Humans; Hypertension; Male; Middle Aged; Pregnancy; Pregnancy Complications, Cardiovascular; Propanolamines; Prospective Studies; Puerperal Disorders; Sex Distribution; Spironolactone; Stroke Volume; Young Adult | 2016 |
[Analysis of the mitochondrial function and ultrastructure in healthy albino mice treated with heart failure medications]
Topics: Animals; Antihypertensive Agents; Atenolol; Cardiotonic Agents; Digoxin; Disease Models, Animal; Diuretics; Electrocardiography; Enalapril; Female; Furosemide; Heart Failure; Isosorbide Dinitrate; Male; Mice; Mitochondria, Heart; Spironolactone | 2017 |
Risk of renal dysfunction in an elderly patient with chronic heart failure.
Topics: Aged, 80 and over; Atrial Fibrillation; Carbazoles; Carvedilol; Diclofenac; Digoxin; Drug Interactions; Drug Therapy, Combination; Female; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic; Myocardial Infarction; Potassium; Potentially Inappropriate Medication List; Propanolamines; Ramipril; Risk Factors; Spironolactone | 2016 |
Impact of SLCO4C1 Genotypes, Creatinine, and Spironolactone on Digoxin Population Pharmacokinetic Variables in Patients With Cardiac Insufficiency.
Topics: Adult; Aged; Aged, 80 and over; Creatinine; Digoxin; Drug Monitoring; Female; Genotype; Heart Failure; Humans; Male; Middle Aged; Models, Biological; Organic Anion Transporters; Retrospective Studies; Spironolactone; Young Adult | 2020 |
Impact of SLCO4C1 Genotypes, Creatinine, and Spironolactone on Digoxin Population Pharmacokinetic Variables in Patients With Cardiac Insufficiency.
Topics: Creatinine; Digoxin; Genotype; Heart Failure; Humans; Organic Anion Transporters; Spironolactone | 2021 |
The Impact of Procyanidin Extracted from Crataegus azarolus on Rats with Induced Heart Failure.
Topics: Animals; Biomarkers; Crataegus; Digoxin; Heart Failure; Male; Natriuretic Peptide, Brain; Peptide Fragments; Proanthocyanidins; Rats; Spironolactone | 2022 |